1. Introduction {#sec1-nutrients-11-01428}
===============

Colorectal cancer (CRC) has a high impact on human health with a lifetime risk in Western European and North American populations of around 5% \[[@B1-nutrients-11-01428]\]. CRC is the third most common cancer worldwide with more than 1.8 million new cases in 2018 and increasing incidence \[[@B1-nutrients-11-01428]\]. A significant part of the risk has been attributed to the Western life style \[[@B2-nutrients-11-01428]\], where a high intake of red and processed meat and alcohol use are linked to a high risk of CRC, and intake of whole grains and dairy products to a low risk of CRC \[[@B3-nutrients-11-01428],[@B4-nutrients-11-01428],[@B5-nutrients-11-01428]\]. With the goal of reducing the number of CRC patients, it is of major importance to identify individuals at high risk of CRC as well as the risk factors involved.

From biological considerations, vitamin A and pro-vitamin A carotenoids are likely to affect colorectal carcinogenesis. Vitamin A is a group of unsaturated nutritional organic compounds that includes retinal, retinol, retinoic acid (RA), and pro-vitamin A carotenoids (e.g., β-carotene, α-carotene, β-cryptoxanthin). Vitamin A sources from food include mainly fat-soluble retinol from animal sources (e.g., liver) and green- or yellow-coloured carotenoids from vegetables (e.g., leafy vegetables, carrots). In the intestine, RA (produced from retinol via two sequential oxidative steps) has been found to govern the regulation of T cells into Th1/Th2/Th17/Tregs pathways and the development of oral immune tolerance via induction of foxp3+ regulatory T cells \[[@B6-nutrients-11-01428]\]. In line with this, RA was found to be necessary for developing gut immune tolerance in response to certain microbes in an experimental human study \[[@B7-nutrients-11-01428]\], and RA-deficiency led to dysregulated T cell response and development of colitis and CRC in a mouse model \[[@B8-nutrients-11-01428]\]. Interestingly, RA is needed for the production of integrin α4β7 necessary for homing of T cells \[[@B9-nutrients-11-01428]\], which is an important initial step in the establishment of gut inflammation, and lack of β7 inhibited the growth of intestinal tumours in an animal model \[[@B10-nutrients-11-01428]\]. Additionally, pro-vitamin A carotenoids have been found to have antioxidant and anti-inflammatory properties mediated via e.g., activation of the nuclear factor (erythroid-derived 2)-like 2 (Nrf-2) pathway \[[@B11-nutrients-11-01428]\] and inhibition of the nuclear factor kappa-B (NF-kB) pathway, respectively, in in vitro studies (reviewed in \[[@B12-nutrients-11-01428]\]). Finally, RA can interact with the nuclear receptors RAR/RXR, which are related to immune responses and inflammation-related pathways \[[@B13-nutrients-11-01428]\]. These data are supported by human and animal studies; low serum retinol levels were identified as a predictor of poor survival in CRC patients \[[@B14-nutrients-11-01428]\], and vitamin A deficiency was associated with a higher rate of CRC development in an animal model \[[@B8-nutrients-11-01428]\]. However, despite the biologically plausible effect of vitamin A intake on CRC risk, the epidemiological evidence is scarce and conflicting \[[@B15-nutrients-11-01428],[@B16-nutrients-11-01428],[@B17-nutrients-11-01428],[@B18-nutrients-11-01428]\]. Individual variability in the bioavailability due to e.g., genetics may, furthermore, complicate the investigations \[[@B19-nutrients-11-01428]\].

CRC is heterogeneous; hence many factors are involved in the disease aetiology. These factors may not be present in every individual patient developing CRC, and their impact may vary among individuals. Thus, even identification of important risk factors in subgroups may be difficult in epidemiological studies. Gene--environment interaction analyses assume that the genetic variants are randomly distributed during the gamete formation. Such analyses may capture risk factors present in specific subgroups of CRC patients that may not easily be captured by epidemiological studies, because an interaction signifies the involvement of both the studied gene and the environmental risk factor in the disease pathway \[[@B20-nutrients-11-01428],[@B21-nutrients-11-01428],[@B22-nutrients-11-01428],[@B23-nutrients-11-01428],[@B24-nutrients-11-01428]\].

Based on the scarce evidence on the role of vitamin A in CRC carcinogenesis, we decided to investigate potential interactions between vitamin A intake and gene variants related to the vitamin A metabolic pathway. We used a nested case-cohort design within the Danish "Diet, Cancer and Health" (DCH) cohort with prospectively collected lifestyle information encompassing 57,053 participants, of which 1038 cases that developed CRC were compared to 1857 controls. Vitamin A intake was analysed as total intake (dietary and supplements combined), dietary intake (retinol and β-carotene as a weighted sum), and supplements separately. We also evaluated potential effects of retinol (mainly from meat and meat products) and β-carotene (mainly from plant foods) separately. We selected functional variants in genes involved in vitamin A metabolism.

2. Materials and Methods {#sec2-nutrients-11-01428}
========================

2.1. Subjects {#sec2dot1-nutrients-11-01428}
-------------

As previously described \[[@B25-nutrients-11-01428]\], the DCH Study is a Danish cohort study designed to investigate the relation between diet, lifestyle, and cancer risk. The cohort consists of 57,053 persons, recruited between December 1993 and May 1997. All the subjects were born in Denmark, and the individuals were 50 to 64 years of age and had no previous cancers reported. Blood samples, anthropometric measures, and questionnaire data on diet and lifestyle were collected at study entry.

2.2. Follow-Up and Endpoints {#sec2dot2-nutrients-11-01428}
----------------------------

As previously described \[[@B20-nutrients-11-01428],[@B21-nutrients-11-01428],[@B22-nutrients-11-01428],[@B26-nutrients-11-01428],[@B27-nutrients-11-01428]\], the present study used a nested case-cohort design. Follow-up was based on the Danish population-based Cancer Registry. Between 1994 and December 31, 2009, 1038 CRC cases were diagnosed. A sub-cohort of 1857 people was randomly selected as controls within the full cohort at time of entry in agreement with the case-cohort study design \[[@B28-nutrients-11-01428]\], and thus without respect to time and disease status. Due to the choice of design with a priori sampling of the sub-cohort, 28 persons were both cases and sub-cohort, and these persons were kept in the analyses. Consequently, 1038 CRC cases and 1857 sub-cohort members were analysed.

2.3. Dietary and Lifestyle Questionnaire {#sec2dot3-nutrients-11-01428}
----------------------------------------

Information on diet, lifestyle, weight, height, medical history, environmental exposures, and socio-economic factors were collected at enrolment using questionnaires and interviews and has been described in detail elsewhere \[[@B21-nutrients-11-01428],[@B29-nutrients-11-01428],[@B30-nutrients-11-01428]\]. In short, the validated food-frequency questionnaire, assessed dietary intake in 12 categories of predefined responses, including 68 food items, ranking from 'never' to 'eight times or more per day'. A section on the intake of dietary supplements included open-ended questions on brands and doses, and categorical questions on frequency of intake and its duration (number of months during the last year) and whether they had taken the supplement in question within the last month. Information on the contents of micronutrients in the different brands of dietary supplement was obtained from producers or distributors of the specific products. For each participant we calculated average daily intake of specific foods and nutrients by means of the software program Food Calc (Copenhagen University, Copenhagen, Denmark) \[[@B31-nutrients-11-01428]\], using population-specific standardized recipes and sex-specific portion sizes. The two forms of vitamin A, retinol and β-carotene, were examined as a weighted sum, where β-carotene was allotted one sixth of the vitamin A-activity compared to retinol \[[@B30-nutrients-11-01428]\]. The vitamin A from supplements was calculated as previously described \[[@B30-nutrients-11-01428]\]. The Pearson correlation coefficients for nutrient intake (adjusted for energy intake) between the food-frequency questionnaire and two times 7 days of weighted records was 0.45 for vitamin A. Red and processed meat was calculated by combining intake of fresh and minced beef, veal, pork, lamb, offal, bacon, smoked or cooked ham, other cold cuts, salami, frankfurter, Cumberland sausage, and liver pâté. Total dietary fiber was estimated by the method of the Association of Official Analytical Chemists \[[@B32-nutrients-11-01428]\], which included lignin and resistant starch. Fiber intake was calculated by multiplying the frequency of consumption of relevant foods (i.e., fruit, vegetables, grains, and leguminous fruit) by their fiber content as determined from national databases of food content as described earlier \[[@B21-nutrients-11-01428],[@B29-nutrients-11-01428],[@B30-nutrients-11-01428]\]. For fruits, only the intake of fresh fruit was examined, whereas intake of vegetables also included estimated contributions from food recipes. Intake of alcohol was inferred from the food-frequency questionnaire and life-style questionnaire as described earlier \[[@B33-nutrients-11-01428]\]. Abstainers were defined as those who reported no intake of alcohol on the food-frequency questionnaire, and no drinking occasions on the lifestyle questionnaire. Smoking status was classified as never, past, or current. Persons smoking at least 1 (one?) cigarette daily during the last year were classified as smokers. Non-steroidal anti-inflammatory drug (NSAID) use ("Aspirin", "Ibuprofen", or "Other pain relievers") was assessed as ≥ 2 pills per month during one year at baseline. Use of hormone replacement therapy (HRT) among women was assessed as current, former, or never user.

2.4. Genotyping and Selection of Polymorphisms {#sec2dot4-nutrients-11-01428}
----------------------------------------------

The polymorphisms were chosen based on their biological function. Promising polymorphisms with known functionality or associated with biological effects suggesting functionality or linkage with functional polymorphisms, and with a reasonable minor allele frequency to study gene--environment interactions, were selected. Buffy coat preparations were stored at minus 150 °C until use. DNA was extracted as described \[[@B34-nutrients-11-01428]\]. The DNA was genotyped by LGC KBioscience (Hoddesdon, UK) by polymerase chain reaction (PCR)-based KASP™ genotyping assay (<http://www.lgcgenomics.com/>). To confirm reproducibility, genotyping was repeated for 10% of the samples, yielding 100% identity.

2.5. Statistics {#sec2dot5-nutrients-11-01428}
---------------

Incidence rate ratios (IRR) and 95% Confidence Intervals (CI) were based on a Cox proportional hazard model fitted to the age at the event of CRC according to the principles for analysis of case-cohort studies \[[@B28-nutrients-11-01428]\], using the approach of Prentice and Langholz \[[@B35-nutrients-11-01428]\]. The main explanatory variables were the genotypes. All models were adjusted for baseline values of risk factors for CRC: body mass index (BMI) (kg/m^2^, continuous), use of hormone replacement therapy (HRT), (never/past/current, among women), intake of dietary fibre (g/day, continuous), red and processed meat intake (g/day, continuous), energy intake (kJ/day), NSAID use (yes/no), and smoking status (never/past/current). Cereal, fibre, fruit, and vegetable consumption were also entered linearly as continuous covariates. All analyses were stratified by gender to ensure that baseline (underlying) hazards were gender specific.

No recessive effects were found. In order to maximize the statistical power for the interactions analyses, the genotypes were, therefore, combined, assuming a dominant model. In the interaction analyses for vitamin A intake and polymorphisms, we present two analyses: in one analysis the vitamin A intake was used as a numeric variable, and in the other, vitamin A intake was entered in the model as a three-level categorical variable, defined via tertile cut-points derived from the empirical distribution of the whole population. Deviation from the Hardy--Weinberg equilibrium in the comparison group was assessed using a Chi-square test. All analyses were performed using the survival package (Terry M. Therneau, version 2.42.4, (Mayo Clinic, Rochester, MN, USA)) of the statistical computational environment R, version 3.5.1 ((R Foundation for Statistical Computing, Vienna, Austria)). A *p* \< 0.05 (2-sided) was considered to indicate a statistically significant test result.

3. Results {#sec3-nutrients-11-01428}
==========

3.1. Baseline Characteristics {#sec3dot1-nutrients-11-01428}
-----------------------------

[Figure 1](#nutrients-11-01428-f001){ref-type="fig"} shows the flowchart of the study participants. Included in the analysis were 1038 cases and a subcohort of 1857 control participants.

[Table 1](#nutrients-11-01428-t001){ref-type="table"} shows the baseline characteristics of 1038 CRC cases and 1857 sub-cohort members including CRC risk factors as previously studied \[[@B20-nutrients-11-01428],[@B21-nutrients-11-01428],[@B22-nutrients-11-01428],[@B24-nutrients-11-01428],[@B27-nutrients-11-01428],[@B36-nutrients-11-01428],[@B37-nutrients-11-01428]\]. There were no associations between vitamin A intakes and risk of CRC. Among the controls, the genotype distributions of the studied polymorphisms were in Hardy--Weinberg equilibrium (results not shown).

3.2. Associations between Polymorphisms and Colorectal Cancer (CRC) {#sec3dot2-nutrients-11-01428}
-------------------------------------------------------------------

[Table 2](#nutrients-11-01428-t002){ref-type="table"} shows the studied polymorphisms (rs1667255 near *TTR*, *FFAR4* rs10882272, rs4889286 near *BCO1*, *BCO1* rs12934922, rs6564851 near *BCO1*, *RARB* rs6800566, *RARB* rs13070407, *ABCA1* rs2791952, *FABP2* rs1799883). The polymorphisms were selected based on known or suggested functional effects such as being involved in the metabolism, transport, or cellular uptake of retinoids.

[Table 3](#nutrients-11-01428-t003){ref-type="table"} shows the crude and adjusted associations between the polymorphisms and CRC. No statistically significant associations were found. In order to maximize the statistical power for the gene--vitamin A interaction analyses, the genotypes were combined, assuming a dominant model.

3.3. Interactions between Polymorphisms and Vitamin A Intake {#sec3dot3-nutrients-11-01428}
------------------------------------------------------------

[Table 4](#nutrients-11-01428-t004){ref-type="table"} shows the results from the interaction analysis between the total dietary intake of vitamin A, β-carotene, and retinol and the targeted polymorphisms, and [Table 5](#nutrients-11-01428-t005){ref-type="table"} shows the results from the tertile analysis of the polymorphisms and total dietary intake of A vitamin, β-carotene, and retinol. There were no statistically significant interactions between the polymorphisms and total intake of vitamin A, β-carotene, and retinol. However, weak associations between *BCO1* rs4889286 and *BCO1* rs6564851 and intake of β-carotene and risk of CRC were seen so that homozygotes of the most common genotype were associated with 20% and 21% increased risk of CRC, respectively (IRR*~BCO1~* ~rs4889286~ = 1.20, 95% CI 0.97--1.49, *P*~for\ interaction~ = 0.08; IRR*~BCO1~* ~rs6564851~ = 1.21, 95%: 0.98--1.50, *P*~for\ interaction~ = 0.09) ([Table 3](#nutrients-11-01428-t003){ref-type="table"}). In tertile analyses, variant carriage of these two genotypes exhibited a dose-dependent decrease in CRC risk; that is, the risk decreased with increasing intake of β-carotene ([Table 5](#nutrients-11-01428-t005){ref-type="table"}). Similar patterns were found for the other polymorphisms and β-carotene. The opposite was observed for retinol, where the risk of CRC increased with increasing intake of retinol. No statistically significant interactions were found between polymorphisms and vitamin A from dietary intake or from supplements, respectively (data not shown), in relation to risk of CRC.

4. Discussion {#sec4-nutrients-11-01428}
=============

This study investigated potential associations between polymorphisms of genes involved in the vitamin A metabolic pathway and CRC and, furthermore, potential interactions between these polymorphisms and dietary intake of vitamin A in relation to CRC risk using the large prospective Danish "Diet, Cancer and Health" cohort. We found no statistically significant associations of the polymorphisms with risk of CRC, and no statistically significant interactions between the selected polymorphisms and intake of vitamin A in relation to CRC risk. When evaluating β-carotene and retinol separately, we did find an indication of opposite CRC risks independent of genotype, where β-carotene was associated with dose-dependent decreased CRC risks, and retinol was associated with dose-dependent increased CRC risks. These effects are most likely driven by plant foods and meat, respectively, and not vitamin A, due to the lack of effect of the polymorphisms.

The epidemiological evidence for the relation between vitamin A and CRC aetiology is scarce and conflicting. First, a large meta-analysis from 2010 found no association between dietary intake of vitamin A from food and supplements and CRC (relative risks (RR) = 0.88; 95% CI: 0.76,1.02 for \>4000 vs. ≤1000 μg/day). The study included thirteen prospective cohort studies from North America and Europe in a pooled analysis comprising 676,141 men and women, including 5454 CRC cases \[[@B17-nutrients-11-01428]\]. Conversely, two prospective studies from 2012 and 2014 found inverse associations of pre-diagnostic blood concentrations of RA with CRC risk. In the first study, nested within the European Prospective Investigation into Cancer and Nutrition (EPIC), plasma concentrations of RA and dietary consumption of RA were determined in 898 colon cancer cases, 501 rectal cancer cases, and 1399 matched controls. An inverse association was observed between high pre-diagnostic plasma RA concentration and a low risk of colon cancer (IRR for the highest quartile = 0.63 (0.46--0.87), *p*~trend~ = 0.01) \[[@B15-nutrients-11-01428]\]. The other study evaluated the association of serum levels of eight antioxidant nutrients, including β-carotene, among postmenopausal women from a subsample of the Women's Health Initiative in relation to CRC risk using repeated measurements. Among 5477 women with baseline serum antioxidant values, 88 incident cases of CRC were identified over a median follow-up time of 12 years. The average serum level of β-carotene was inversely associated with lowered risk of CRC (HRs for highest vs. lowest tertile 0.54 (0.31--0.96)) \[[@B16-nutrients-11-01428]\]. A retrospective case-control study, the Japanese Fukuoka CRC study, published in 2012, found that intake of vitamin A (retinol-equivalent) was inversely related to CRC risk in women, but positively related in men \[[@B18-nutrients-11-01428]\]. Thus, these studies do not support the notion that a high vitamin A intake protects against CRC. Our genetic study found no support for a significant role of vitamin A in the etiology of CRC.

Furthermore, vitamin A and, especially, carotenoid absorption from supplements, may be hampered by being less efficient compared to dietary intake, especially from formulations not containing many lipids \[[@B46-nutrients-11-01428]\]. Therefore, in addition to analysing the total vitamin A intake (i.e., from both diet and supplements), we analysed the data for dietary intake and intake from supplements separately. No statistically significant interactions between the polymorphisms and the intake of vitamin A from dietary sources or from supplements were found. Similarly, inconsistent associations were found for CRC risk and supplemental vitamin A in a recent review \[[@B47-nutrients-11-01428]\]. However, the power in the present study to perform such analysis was limited.

Advantages and limitations with the study design have been described in previous studies \[[@B20-nutrients-11-01428],[@B21-nutrients-11-01428],[@B22-nutrients-11-01428],[@B26-nutrients-11-01428],[@B27-nutrients-11-01428],[@B48-nutrients-11-01428]\]. The main advantage of this study is the prospective study design including the collection of dietary and lifestyle factors before diagnosis which eliminates the risk of recall bias. This design has previously proven its value by the identification of GxE interactions between e.g., meat and pattern recognition receptors \[[@B20-nutrients-11-01428],[@B21-nutrients-11-01428]\]. Changes in dietary and life-style habits during follow-up are possible and, if present, would result in lower power to detect real differences between cases and the comparison group. The "Diet, Cancer and Health" cohort is relatively homogenous, reducing population-specific differences in genetics and dietary patterns seen in larger multicentre studies. The disadvantage of this prospective study is the limited power to study gene--environment interactions. Residual confounding of lifestyle factors might be present; however, the study design using GxE interaction analysis with polymorphisms selected on biological basis strongly reduces the risk of bias. Alcohol intake could potentially have affected the results. In a case-control study, an association between the serum retinol level and head and neck cancer was found that was not present among regular alcohol consumers \[[@B39-nutrients-11-01428]\]. A high number of alcohol drinkers in our study may, therefore, result in a reduced ability to detect an interaction between carotenoids and CRC despite the adjustment for alcohol intake. Finally, the null-result of this study is dependent on several premises. First, the selected polymorphisms are either functional themselves or in linkage with functional polymorphisms involved in vitamin A metabolism. This criteria, however, seems to be fulfilled \[[@B19-nutrients-11-01428],[@B38-nutrients-11-01428],[@B39-nutrients-11-01428],[@B40-nutrients-11-01428],[@B41-nutrients-11-01428],[@B42-nutrients-11-01428],[@B43-nutrients-11-01428],[@B45-nutrients-11-01428]\]. Next, the intake of vitamin A should be sufficiently distributed among the study participants to allow the evaluation of variable intakes. As shown in [Table 1](#nutrients-11-01428-t001){ref-type="table"}, the intake of vitamin A seems to be well-distributed among the participants. However, nearly all participants appeared to have a sufficient vitamin A intake, as the recommended intake of vitamin A is 700 and 900 RE/day for women and men, respectively, which was generally surpassed.

5. Conclusions {#sec5-nutrients-11-01428}
==============

In conclusion, this large gene--environment interaction analysis, using a nested case-cohort design within the Danish "Diet, Cancer and Health" cohort with prospectively collected lifestyle information encompassing 57,053 participants, found no support of an involvement of vitamin A in CRC aetiology.
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nutrients-11-01428-t001_Table 1

###### 

Participant description.

  Variable                               Cases        Sub-Cohort                IRR (95% CI) ^1^                                                 
  -------------------------------------- ------------ ------------------------- --------------------------------------- ------------------------ ------------------------
  Total                                  1038 (100)                             1857 (100)                                                       
  **Sex**                                                                                                                                        
  Females                                462 (45)                               865 (47)                                                         
  Males                                  576 (55)                               992 (53)                                                         
  Age at entry                                        58 (51--65)                                                       56 (51--64)              
  BMI (kg/m^2^)                                       26 (21--34) (3)                                                   26 (21--33)              1.05 (1.01--1.10) ^5^
  **Food intake**                                                                                                                                
  Alcohol (g/day) ^2^                                 15 (1--71)                                                        14 (1--66)               1.03 (0.98--1.07) ^6^
  Dietary fiber (g/day)                               20 (11--33)                                                       21 (11--34)              0.83 (0.65--1.08) ^7^
  Red and processed meat (g/day)                      112 (46--233)                                                     109 (41--236)            1.01 (0.97--1.06) ^8^
  Total energy (kJ/day)                               9681 (6115--14,712) (4)                                           9633 (5922--14,820)      1.00 (1.00--1.00) ^9^
  Fruits (g/day)                                      166 (24--493) (4)                                                 176 (27--546)            0.98 (0.95--1.02) ^10^
  Vegetables (g/day)                                  153 (46--367) (4)                                                 163 (50--372)            1.03 (0.98--1.09) ^11^
  Fruit and vegetables (g/day)                        331 (98-796) (4)                                                  350 (102--818)           1.00 (0.97--1.02) ^12^
  **Vitamin A intake**                                                                                                                           
  Vitamin A (total) (RE/day)                          1980 (759--4332) (0)                                              1992 (800--4398) (4)     0.98 (0.90--1.06) ^13^
  Vitamin A (dietary) (RE/day)                        1684 (697--4189) (0)                                              1693 (670--3966) (4)     1.03 (0.94--1.13)
  β-Carotene (total) (µg/day)                         2993 (707--12,424) (0)                                            3177 (761--12,837) (4)   0.99 (0.89--1.10) ^14^
  Retinol (total) (µg/day)                            1033 (285--2661) (0)                                              966 (272--2550) (4)      1.04 (0.91--1.18) ^15^
  Vitamin A (supplements) (%, *n*)       455 (44)                               882 (48) \[[@B4-nutrients-11-01428]\]                            0.87 (0.74--1.03)
  Vitamin A (supplements) ^3^ (RE/day)                624 (72--1011) (0)                                                640 (57--1500) (4)       
  **Smoking status**                                                                                                                             
  Never                                  306 (29)                               621 (33)                                                         1.00 (ref.)
  Past                                   322 (31)                               536 (29)                                                         1.12 (0.91--1.38)
  Current                                410 (39)                               699 (38)                                                         1.18 (0.97--1.44)
  **NSAID use ^4^**                                                                                                                              
  No                                     716 (70)                               1275 (69)                                                        1.00 (ref.)
  Yes                                    313 (30)                               568 (31)                                                         0.99 (0.84--1.18)
  **HRT use among women**                                                                                                                        
  Never                                  279 (60)                               455 (53)                                                         1.00 (ref.)
  Past                                   62 (13)                                137 (16)                                                         0.65 (0.45--0.92)
  Current                                121 (26)                               273 (32)                                                         0.70 (0.53--0.92)

Values are expressed as medians (5th and 95th percentiles) or as fractions (%). Number of missing observations in parenthesis. IRR, incidence rate ratio; CRC, colorectal cancer; CI, confidence interval; BMI, body mass index; NSAID, non-steroidal anti-inflammatory drug; HRT, hormone replacement therapy. ^1^ IRRs for CRC estimated by the Cox proportional hazards model mutually adjusted for all variables, with age as the underlying time axis, and stratified by gender, so that the underlying baseline hazards are gender specific. ^2^ Among current drinkers. ^3^ For those taking supplements. ^4^ NSAID use is defined as ≥2 pills per month for one year. ^5^ Risk estimate per 2 kg/m^2^ increment of BMI. ^6^ Risk estimate for the increment of 10 g alcohol per day. ^7^ Risk estimate for the increment of 10 g dietary fibers per day. ^8^ Risk estimate for the increment of 25 g red and processed meat per day. ^9^ Risk estimate for the increment of 1 kJ energy per day (incl alcohol). ^10^ Risk estimate for the increment of 50 fruits per day. ^11^ Risk estimate for the increment of 50 vegetables per day. ^12^ Risk estimate for the increment of 50 g fruits or vegetables per day. ^13^ Risk estimate for the increment of 1000 retinol equivalents (RE) per day. ^14^ Risk estimate for the increment of 4000 µg β-carotene per day. ^15^ Risk estimate for the increment of 1000 µg retinol per day.

nutrients-11-01428-t002_Table 2

###### 

Suggested biological effects of the selected polymorphisms.

  Gene                                        Rs-Number    MAF    Function/Effect of Polymorphism                                            Feature                  Reference
  ------------------------------------------- ------------ ------ -------------------------------------------------------------------------- ------------------------ ---------------------------------------------------------
  **RA Transport**                                                                                                                                                    
  near *TTR*                                  rs1667255    0.50   The SNP has been associated with circulating retinol levels                Downstream of gene       \[[@B38-nutrients-11-01428],[@B39-nutrients-11-01428]\]
  *FFAR4*                                     rs10882272   0.39   \-                                                                         3′ UTR                   \[[@B38-nutrients-11-01428],[@B39-nutrients-11-01428]\]
  **Cleavage β-Carotene into RA**                                                                                                                                     
  near *BCO1*                                 rs4889286    0.49   Associates with plasma β-carotene                                          Upstream of gene         \[[@B40-nutrients-11-01428]\]
  *BCO1*                                      rs12934922   0.23   \-                                                                         Missense (Arg to Ser)    \[[@B40-nutrients-11-01428],[@B41-nutrients-11-01428]\]
  near *BCO1*                                 rs6564851    0.48   \-                                                                         Upstream of gene         \[[@B40-nutrients-11-01428]\]
  **RA Receptor**                                                                                                                                                     
  *RARB*                                      rs6800566    0.25   Associated with immune response and/or cytokine levels after stimulation   Intron                   \[[@B42-nutrients-11-01428]\]
  *RARB*                                      rs13070407   0.20   \-                                                                         Intron                   
  **Uptake of β-Carotene into Enterocytes**                                                                                                                           
  *ABCA1*                                     rs2791952    0.14   Associated with β-carotene bioavailability                                 Intron                   \[[@B43-nutrients-11-01428],[@B44-nutrients-11-01428]\]
  *FABP2*                                     rs1799883    0.25   Affect the promotor activity in in vitro promotor assay                    Missense (Ala to Thr))   \[[@B45-nutrients-11-01428]\]

MAF, minor allele frequencies in the population; RA, retinoic acid; SNP, single nucleotide polymorphism; UTR, un-translated region. Proteins encoded by genes: transthyretin encoded by TTR, free fatty acid receptor 4 endcoded by FFAR4, beta-carotene oxygenase 1 encoded by BCO1, retinoic acid receptor beta encoded by RARB, ATP binding cassette subfamily A member 1 encoded by ABCA1, fatty acid binding protein 2 encoded by FABP2.

nutrients-11-01428-t003_Table 3

###### 

Incidence rate ratios (IRR) for associations between the polymorphisms and colorectal cancer (CRC).

  Polymorphism         *n*~cases~ (%)   *n*~sub-cohort~ (%)   IRR (95% CI) ^1^    IRR (95% CI) ^2^    *p*-Value ^3^
  -------------------- ---------------- --------------------- ------------------- ------------------- ---------------
  *TTR* rs1667255                                                                                     
  AA                   360 (39)         675 (39)              1.00 (ref.)         1.00 (ref.)         
  CA                   426 (46)         794 (46)              0.99 (0.83--1.19)   1.03 (0.86--1.23)   0.76
  CC                   139 (15)         270 (16)              0.97 (0.76--1.24)   0.99 (0.77--1.27)   0.93
  CA + CC              565 (61)         1064 (61)             0.99 (0.84--1.17)   1.02 (0.86--1.21)   0.84
  CC vs. AA + CA       139 (15)         270 (16)              0.97 (0.78--1.22)   0.97 (0.78--1.22)   0.82
  *FFAR4* rs10882272                                                                                  
  TT                   395 (43)         699 (40)              1.00 (ref.)         1.00 (ref.)         
  TC                   414 (45)         811 (47)              0.92 (0.77--1.10)   0.92 (0.77--1.10)   0.35
  CC                   116 (13)         232 (13)              0.90 (0.69--1.16)   0.93 (0.71--1.21)   0.57
  TC + CC              530 (57)         1043 (60)             0.91 (0.78--1.08)   0.92 (0.78--1.09)   0.33
  *BCO1* rs4889286                                                                                    
  TT                   250 (27)         451 (26)              1.00 (ref.)         1.00 (ref.)         
  TC                   451 (48)         862 (49)              0.95(0.78--1.15)    0.96 (0.79--1.17)   0.70
  CC                   237 (25)         446 (25)              0.97(0.77--1.21)    0.99 (0.79--1.25)   0.97
  TC + CC              688 (73)         1308 (74)             0.96(0.80--1.15)    0.97 (0.81--1.17)   0.77
  *BCO1* rs12934922                                                                                   
  AA                   274 (30)         541 (31)              1.00 (ref.)         1.00 (ref.)         
  TA                   437 (47)         837 (48)              1.05 (0.87--1.27)   1.05 (0.87--1.28)   0.61
  TT                   211 (23)         364 (21)              1.18 (0.94--1.48)   1.18 (0.93--1.48)   0.18
  TA + TT              648 (70)         1201 (69)             1.09 (0.91--1.30)   1.09 (0.91--1.31)   0.36
  *BCO1* rs6564851                                                                                    
  GG                   252 (27)         467 (27)              1.00 (ref.)         1.00 (ref.)         
  TG                   444 (48)         854 (49)              0.96 (0.79--1.17)   0.98 (0.80--1.19)   0.82
  TT                   230 (25)         433 (25)              1.00 (0.80--1.25)   1.03 (0.82--1.30)   0.80
  TG + TT              674 (73)         1287 (73)             0.97 (0.81--1.17)   0.99 (0.82--1.20)   0.96
  TT vs. GG + TG       230 (25)         433 (25)              1.02 (0.85--1.24)   1.05 (0.86--1.27)   0.65
  *RARB* rs6800566                                                                                    
  GG                   397 (43)         735 (42)              1.00 (ref.)         1.00 (ref.)         
  GA                   421 (45)         830 (47)              0.93 (0.78--1.11)   0.94 (0.79--1.12)   0.51
  AA                   108 (12)         199 (11)              1.00 (0.76--1.31)   0.98 (0.75--1.30)   0.92
  GA + AA              529 (57)         1029 (58)             0.94 (0.80--1.11)   0.95 (0.80--1.12)   0.56
  *RARB* rs13070407                                                                                   
  TT                   536 (57)         985 (56)              1.00 (ref.)         1.00 (ref.)         
  TC                   344 (37)         672 (38)              0.96 (0.81--1.14)   0.95 (0.80--1.14)   0.61
  CC                   60 (6)           110 (6)               1.04 (0.74--1.46)   1.06 (0.75--1.50)   0.75
  TC + CC              404 (43)         782 (44)              0.97 (0.83--1.15)   0.97 (0.82--1.14)   0.71
  CC vs. TT + TC       60 (6)           110 (6)               1.05 (0.75--1.47)   1.08 (0.77--1.51)   0.66
  *ABCA1* rs2791952                                                                                   
  CC                   720 (77)         1389 (79)             1.00 (ref.)         1.00 (ref.)         
  TC                   211 (22)         341 (19)              1.17 (0.96--1.43)   1.15 (0.93--1.40)   0.19
  TT                   7 (1)            27 (2)                0.48 (0.21--1.10)   0.51 (0.22--1.19)   0.13
  TC + TT              218 (23)         368 (21)              1.12 (0.92--1.36)   1.10 (0.90--1.35)   0.34
  *FABP2* rs1799883                                                                                   
  GG                   505 (55)         908 (52)              1.00 (ref.)         1.00 (ref.)         
  GA                   356 (39)         706 (41)              0.89 (0.75--1.05)   0.89 (0.74--1.06)   0.18
  AA                   62 (7)           125 (7)               0.89 (0.64--1.24)   0.88 (0.63--1.23)   0.45
  GA + AA              418 (45)         831 (48)              0.89 (0.75--1.04)   0.88 (0.75--1.05)   0.16

^1^ IRRs for CRC estimated by the Cox proportional hazards model with age as the underlying time axis, and stratified by gender, so that the underlying baseline hazards are gender specific. 95% CI is based on Wald's tests. ^2^ In addition, adjusted for smoking status, alcohol, HRT status (women only), BMI, use of NSAID, energy consumption, intake of red and processed meat dietary fiber, fruit and vegetable intake. ^3^ *p*-value for adjusted risk estimates. Number of missing observations; *TTR* rs1667255 230, *FFAR4* rs10882272 227, *BCO1* rs4889286 197, *BCO1* rs12934922 230, *BCO1* rs6564851 214, *RARB* rs6800566 203, *RARB* rs13070407 186, *ABCA1* rs2791952 199, *FABP2* rs1799883 232.

nutrients-11-01428-t004_Table 4

###### 

Interactions between polymorphisms and dietary intake of vitamin A, β-carotene, and retinol and risk of colorectal cancer.

                       Vitamin A           β-Carotene   Retinol                                        
  -------------------- ------------------- ------------ ------------------- ------ ------------------- ------
  *TTR* rs1667255                                                                                      
  AA                   0.98 (0.88--1.09)   0.61         1.02 (0.89--1.17)   0.92   0.99 (0.83--1.19)   0.32
  CA + CC              1.01 (0.91--1.13)                1.03 (0.91--1.17)          1.11 (0.94--1.32)   
  *FFAR4* rs10882272                                                                                   
  TT                   1.05 (0.94--1.17)   0.25         1.05 (0.93--1.20)   0.45   1.16 (0.97--1.38)   0.21
  TC + CC              0.97 (0.87--1.07)                1.00 (0.88--1.13)          1.01 (0.85--1.19)   
  *BCO1* rs4889286                                                                                     
  TT                   1.07 (0.91--1.26)   0.33         1.20 (0.97--1.49)   0.08   1.04 (0.83--1.31)   0.85
  TC + CC              0.98 (0.90--1.08)                1.00 (0.90--1.12)          1.07 (0.92--1.24)   
  *BCO1* rs12934922                                                                                    
  AA                   1.00 (0.86--1.15)   0.92         0.94 (0.79--1.13)   0.20   1.16 (0.96--1.40)   0.21
  TA + TT              1.00 (0.91--1.10)                1.06 (0.94--1.20)          1.00 (0.85--1.18)   
  *BCO1* rs6564851                                                                                     
  GG                   1.06 (0.90--1.25)   0.37         1.21 (0.98--1.50)   0.09   1.02 (0.81--1.28)   0.77
  TG + TT              0.98 (0.90--1.08)                1.02 (0.91--1.14)          1.06 (0.91--1.23)   
  *RARB* rs6800566                                                                                     
  GG                   0.98 (0.88--1.10)   0.53         0.97 (0.85--1.12)   0.23   1.10 (0.92--1.31)   0.61
  GA + AA              1.03 (0.92--1.14)                1.06 (0.94--1.20)          1.04 (0.88--1.22)   
  *RARB* rs13070407                                                                                    
  TT                   1.02 (0.92--1.13)   0.46         1.08 (0.96--1.22)   0.05   1.01 (0.86--1.19)   0.35
  TC + CC              0.97 (0.86--1.09)                0.92 (0.79--1.08)          1.13 (0.93--1.36)   
  *ABCA1* rs2791952                                                                                    
  CC                   0.98 (0.90--1.08)   0.43         0.99 (0.88--1.12)   0.52   1.09 (0.95--1.27)   0.47
  TC + TT              1.05 (0.90--1.22)                1.04 (0.91--1.21)          1.00 (0.80--1.25)   
  *FABP2* rs1799883                                                                                    
  GG                   1.00 (0.89--1.11)   0.73         1.04 (0.92--1.18)   0.67   1.09 (0.93--1.29)   0.35
  GA + AA              0.97 (0.87--1.09)                1.01 (0.87--1.16)          0.98 (0.82--1.18)   

Risk estimate for the increment of 1000 retinol equivalents (RE) per day. IRR, incidence rate ratio; CI, confidence interval (Vitamin A: Risk estimate for the increment of 1000 retinol equivalents (RE) per day, β-Carotene: Risk estimate for the increment of 4000 μg per day, Retinol Risk estimate for the increment of 1000 μg per day). ^1^ *p*-value for interaction between genotype and intake of vitamin A, β-carotene or retinol for adjusted risk estimates. Number of missing observations; *TTR* rs16672552 294, *FFAR4* rs10882272 292, *BCO1* rs4889286 263, *BCO1* rs12934922 291, *BCO1* rs6564851 279, *RARB* rs6800566 266, *RARB* rs13070407 251, *ABCA1* rs2791952 264, *FABP2* rs1799883 297.

nutrients-11-01428-t005_Table 5

###### 

Tertile analyses of polymorphisms and dietary intake of vitamin A, β-carotene, and retinol.

                       1\. Tertile   2\. Tertile   3\. Tertile   1\. Tertile         2\. Tertile         3\. Tertile         *p*    1\. Tertile   2\. Tertile   3\. Tertile   1\. Tertile         2\. Tertile         3\. Tertile         *p*
  -------------------- ------------- ------------- ------------- ------------------- ------------------- ------------------- ------ ------------- ------------- ------------- ------------------- ------------------- ------------------- ------
                       Nc/Ns         Nc/Ns         Nc/Ns         IRR (95% CI)        IRR (95% CI)        IRR (95% CI)               Nc/Ns         Nc/Ns         Nc/Ns         IRR (95% CI)        IRR (95% CI)        IRR (95% CI)        
  *TTR* rs1667255      Vitamin A                                                                         Retinol                                                                                                                          
  AA                   119/216       126/228       105/219       1.00                1.02 (0.66--1.57)   0.93 (0.58--1.49)          110/221       127/237       113/205       1.00                1.02 (0.66--1.58)   1.02 (0.63--1.63)   
  CA + CC              185/335       178/340       190/359       1.03 (0.70--1.53)   0.99 (0.67--1.48)   1.04 (0.68--1.59)   0.83   162/355       178/320       213/359       0.93 (0.62--1.38)   1.08 (0.72--1.62)   1.14 (0.74--1.76)   0.66
                                                                 β-carotene                                                                                                                                                               
  AA                   131/199       118/229       101/235       1.00                0.90 (0.57--1.42)   0.77 (0.46--1.29)                                                                                                                
  CA + CC              196/327       196/348       161/359       0.95 (0.65--1.40)   0.98 (0.65--1.49)   0.83 (0.51--1.36)   0.79                                                                                                         
  *FFAR4* rs10882272   Vitamin A                                                                         Retinol                                                                                                                          
  TT                   129/236       134/230       125/213       1.00                1.16 (0.76--1.76)   1.19 (0.76--1.87)          118/231       128/244       142/204       1.00                0.97 (0.64--1.49)   1.31 (0.83--2.06)   
  TC + CC              172/317       168/341       174/363       1.07 (0.73--1.58)   0.95 (0.64--1.41)   0.98 (0.65--1.48)   0.36   154/344       175/314       185/363       0.90 (0.60--1.34)   1.07 (0.71--1.59)   0.97 (0.63--1.48)   0.18
                                                                 β-carotene                                                                                                                                                               
  TT                   139/217       140/238       109/224       1.00                1.09 (0.71--1.68)   0.90 (0.54--1.50)                                                                                                                
  TC + CC              187/311       172/340       155/370       0.99 (0.68--1.45)   0.90 (0.59--1.36)   0.79 (0.49--1.28)   0.67                                                                                                         
  *BCO1* rs4889286     Vitamin A                                                                         Retinol                                                                                                                          
  TT                   78/162        79/140        83/142        1.00                1.12 (0.66--1.89)   1.22 (0.71--2.09)          69/145        91/163        80/136        1.00                1.06 (0.63--1.78)   1.10 (0.62--1.95)   
  TC + CC              230/397       227/437       217/439       1.18 (0.77--1.80)   1.09 (0.71--1.68)   1.08 (0.68--1.70)   0.48   206/438       217/399       251/436       0.98 (0.62--1.53)   1.08 (0.69--1.70)   1.12 (0.70--1.79)   0.98
                                                                 β-carotene                                                                                                                                                               
  TT                   77/151        87/145        76/148        1.00                1.27 (0.75--2.16)   1.14 (0.63--2.04)                                                                                                                
  TC + CC              253/380       233/440       188/453       1.31 (0.86--2.01)   1.16 (0.73--1.82)   0.93 (0.55--1.57)   0.12                                                                                                         
  *BCO1* rs12934922    Vitamin A                                                                         Retinol                                                                                                                          
  AA                   89/178        98/155        85/192        1.00                1.23 (0.75--2.01)   0.96 (0.58--1.59)          73/181        91/187        108/157       1.00                1.09 (0.65--1.81)   1.61 (0.95--2.75)   
  TA + TT              214/376       203/414       212/387       1.18 (0.78--1.79)   1.04 (0.69--1.58)   1.16 (0.74--1.79)   0.23   200/395       209/371       220/411       1.27 (0.82--1.96)   1.38 (0.88--2.17)   1.25 (0.78--2.00)   0.05
                                                                 β-carotene                                                                                                                                                               
  AA                   94/154        103/170       75/201        1.00                1.09 (0.66--1.80)   0.70 (0.39--1.24)                                                                                                                
  TA + TT              230/374       212/409       187/394       1.05 (0.69--1.59)   0.98 (0.63--1.53)   0.91 (0.55--1.51)   0.27                                                                                                         
  *BCO1* rs6564851     Vitamin A                                                                         Retinol                                                                                                                          
  GG                   79/168        81/145        82/146        1.00                1.11 (0.66--1.87)   1.20 (0.70--2.05)          73/153        91/166        78/140        1.00                1.06 (0.63--1.77)   1.08 (0.61--1.90)   
  TG + TT              224/388       222/431       215/434       1.19 (0.78--1.82)   1.11 (0.72--1.69)   1.09 (0.69--1.72)   0.53   199/426       215/392       247/435       0.98 (0.63--1.52)   1.11 (0.71--1.73)   1.13 (0.71--1.80)   0.95
                                                                 β-carotene                                                                                                                                                               
  GG                   78/155        85/151        79/153        1.00                1.23 (0.72--2.09)   1.14 (0.64--2.05)                                                                                                                
  TG + TT              248/379       225/432       188/442       1.30 (0.85--1.99)   1.15 (0.73--1.82)   0.98 (0.58--1.66)   0.19                                                                                                         
  *RARB* rs6800566     Vitamin A                                                                         Retinol                                                                                                                          
  GG                   132/239       133/246       123/232       1.00                0.98 (0.65--1.48)   1.04 (0.66--1.63)          119/250       138/239       131/228       1.00                1.19 (0.78--1.82)   1.14 (0.73--1.80)   
  GA + AA              171/325       170/330       176/350       0.95 (0.65--1.40)   0.96 (0.65--1.43)   0.96 (0.64--1.45)   0.96   155/334       165/326       197/345       1.00 (0.67--1.49)   1.01 (0.68--1.51)   1.16 (0.76--1.77)   0.63
                                                                 β-carotene                                                                                                                                                               
  GG                   142/229       142/241       104/247       1.00                1.08 (0.70--1.67)   0.81 (0.48--1.36)                                                                                                                
  GA + AA              185/305       171/346       161/354       0.99 (0.68--1.46)   0.91 (0.60--1.36)   0.87 (0.54--1.38)   0.51                                                                                                         
  *RARB* rs13070407    Vitamin A                                                                         Retinol                                                                                                                          
  TT                   168/305       179/313       177/348       1.00                1.10 (0.76--1.60)   1.01 (0.68--1.49)          161/315       166/323       197/328       1.00                0.97 (0.67--1.41)   1.12 (0.74--1.67)   
  TC + CC              141/257       129/264       122/239       1.08 (0.74--1.59)   0.92 (0.62--1.37)   1.02 (0.66--1.58)   0.46   115/270       144/243       133/247       0.87 (0.58--1.30)   1.11 (0.75--1.65)   1.01 (0.66--1.54)   0.38
                                                                 β-carotene                                                                                                                                                               
  TT                   184/287       167/332       173/347       1.00                0.90 (0.60--1.33)   0.93 (0.59--1.48)                                                                                                                
  TC + CC              147/247       152/255       93/258        0.99 (0.68--1.45)   1.08 (0.72--1.62)   0.67 (0.40--1.13)   0.06                                                                                                         
  *ABCA1* rs2791952    Vitamin A                                                                         Retinol                                                                                                                          
  CC                   237/435       237/452       227/467       1.00                0.99 (0.72--1.36)   0.97 (0.68--1.37)          207/456       242/444       252/454       1.00                1.18 (0.85--1.63)   1.19 (0.84--1.70)   
  TC + TT              69/124        71/124        74/113        1.03 (0.64--1.64)   1.06 (0.66--1.68)   1.18 (0.72--1.95)   0.78   68/126        67/118        79/117        1.28 (0.81--2.04)   1.13 (0.69--1.84)   1.33 (0.81--2.21)   0.52
                                                                 β-carotene                                                                                                                                                               
  CC                   251/421       250/446       200/487       1.00                1.03 (0.74--1.46)   0.79 (0.52--1.20)                                                                                                                
  TC + TT              78/114        69/131        67/116        1.06 (0.67--1.68)   0.96 (0.60--1.55)   1.11 (0.64--1.93)   0.24                                                                                                         
  *FABP2* rs1799883    Vitamin A                                                                         Retinol                                                                                                                          
  GG                   159/284       167/312       165/296       1.00                0.94 (0.65--1.37)   1.03 (0.69--1.55)          154/300       154/287       183/305       1.00                0.97 (0.66--1.43)   1.10 (0.73--1.65)   
  GA + AA              146/266       133/257       128/284       0.93 (0.63--1.37)   0.92 (0.62--1.38)   0.82 (0.53--1.25)   0.57   118/267       147/273       142/267       0.85 (0.57--1.27)   0.98 (0.66--1.45)   0.94 (0.61--1.45)   0.68
                                                                 β-carotene                                                                                                                                                               
  GG                   183/300       161/288       147/304       1.00                1.04 (0.70--1.53)   0.91 (0.57--1.45)                                                                                                                
  GA + AA              144/229       148/287       115/291       1.01 (0.69--1.49)   0.90 (0.60--1.35)   0.74 (0.46--1.20)   0.58                                                                                                         

Nc, Ncases; Ns, Nsubcohort. Number of missing observations; *TTR* rs1667255 294, *FFAR4* rs10882272 292, *BCO1* rs4889286 263, *BCO1* rs12934922 291, *BCO1* rs6564851 279, *RARB* rs6800566 266, *RARB* rs13070407 251, *ABCA1* rs2791952 264, *FABP2* rs1799883 297. Vitamin A 1st tertile 300--1600 RE/day, 2nd tertile 1600--2500 RE/day, 3rd tertile 2500--15,500 RE/day. Retinol 1st tertile 90--730 μg/day, 2nd tertile 730--1280 μg/day, 3rd tertile 1280--5660 μg/day. β-carotene l 1st tertile 160--2180 μg/day, 2nd tertile 2180--4710 μg/day, 3rd tertile 4710--54,180 μg/day.
